We canβt show the full text here under this license. Use the link below to read it at the source.
Prophylactic effect of intraoperative sodium oxybate on postoperative delirium in older patients undergoing major orthopedic surgery: a randomized clinical trial
Sodium oxybate given during surgery may reduce confusion after major bone surgery in older patients
AI simplified
Abstract
Prophylactic intraoperative sodium oxybate reduced postoperative delirium (POD) incidence to 7.3% in older patients undergoing morning orthopedic surgery.
- The overall POD incidence was 10.3% in the sodium oxybate group and 13.5% in the placebo group, with no significant difference.
- Morning surgery patients showed a relative risk reduction in POD incidence when treated with sodium oxybate compared to placebo.
- No significant protective effect of sodium oxybate was observed in patients undergoing afternoon surgery.
- No differences in delirium severity, onset timing, or duration were noted among patients who experienced POD.
- Safety assessments revealed no significant adverse effects on anesthesia recovery or hemodynamic parameters.
AI simplified
Key numbers
7.3%
Decrease in POD Incidence
POD incidence in sodium oxybate group during morning surgeries.
18.5%
POD Incidence in Control Group
POD incidence in control group during morning surgeries.
8.5%
No Effect in Afternoon Surgeries
POD incidence in control group during afternoon surgeries.